Company Filing History:
2 out of 160 
1 out of 80 Years Active: 2000-2012
Title: Jon Swanson: Innovator in Controlled-Release Nanoparticulate Compositions
Introduction
Jon Swanson is a notable inventor based in North Wales, PA (US). He has made significant contributions to the field of nanoparticulate formulations, holding a total of 3 patents. His work focuses on developing innovative compositions that enhance the delivery and effectiveness of pharmaceutical agents.
Latest Patents
Swanson's latest patents include groundbreaking formulations. One of his notable inventions is the "Controlled-release nanoparticulate compositions." This patent describes formulations that comprise a nanoparticulate agent and a rate-controlling polymer, which prolongs the release of the agent for a duration ranging from about 2 to 24 hours or longer. Another significant patent is for "Glipizide compositions," which involves nanoparticulate formulations of glipizide with an effective average particle size of less than about 2 microns. These innovations are crucial for improving drug delivery systems.
Career Highlights
Throughout his career, Jon Swanson has worked with prominent companies in the pharmaceutical industry. He has been associated with Alkermes Pharma Ireland Limited and Elan Pharma International Limited, where he contributed to the development of advanced drug formulations. His expertise in nanoparticulate technology has positioned him as a key player in the field.
Collaborations
Swanson has collaborated with esteemed professionals in his field, including Rajeev A Jain and Robert Hontz. These collaborations have further enriched his research and development efforts, leading to innovative solutions in drug delivery.
Conclusion
Jon Swanson's contributions to controlled-release nanoparticulate compositions highlight his role as an influential inventor in the pharmaceutical industry. His patents and career achievements reflect a commitment to advancing drug delivery technologies.